跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DI-ERTRIDE TABLET 25 MG - HSA Drug Approval Details
Approvals
/
HSA
/
DI-ERTRIDE TABLET 25 MG
Approved
THERAPEUTIC
DI-ERTRIDE TABLET 25 MG
BEACONS PHARMACEUTICALS PTE LTD (SINGAPORE)
🇸🇬 Health Sciences Authority
Approval Date
Mar 16, 1988
Approval ID
fc1feef5f615a20b
Company
BEACONS PHARMACEUTICALS PTE LTD (SINGAPORE)
Type
Therapeutic
Approval Details
Approval Id
fc1feef5f615a20b
Drug Name
DI-ERTRIDE TABLET 25 MG
Product Name
DI-ERTRIDE TABLET 25 MG
Approval Number
SIN00108P
Approval Date
1988-03-16
Registrant
BEACONS PHARMACEUTICALS PTE. LTD.
Licence Holder
BEACONS PHARMACEUTICALS PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
C03AA03
Atc Item Name
hydrochlorothiazide
Pharma Manufacturer Name
BEACONS PHARMACEUTICALS PTE. LTD.
Active Ingredients
HYDROCHLOROTHIAZIDE
25 mg
HYDROCHLOROTHIAZIDE
25 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 16, 1988
Approval ID
fc1feef5f615a20b
Type
Therapeutic
Back to HSA Approvals